The US pays—by far—the highest prices for on-patent prescription drugs of any country on earth. The White House just issued an executive order purporting to fix this problem. But the proposed solution—that the US should pay the “most-favored-nation” price for prescription drugs to “bring prices fo...

How can development cooperation stay relevant in a world where many governments are prioritising national economic and security interests and retreating from multilateralism? This blog discusses the 2025 Development Leaders Conference (DLC), coming up next month in Hamburg.

There are more than 450 AI applications targeting health or education outcomes in low- and middle-income countries, but not every application will prove cost-effective. How can the development sector make smart bets when we don’t yet have a conclusive evidence base on what interventions work?

As the second season of Pandemic Proof comes to a close, host Javier Guzman reflects on the progress made in pandemic preparedness since COVID-19, the challenges we still face, and the rapidly shifting global landscape that will shape what comes next.

The Trump administration unveiled an overview of its FY2026 budget request on Friday. While short on details, the document offers a grim forecast for US development and humanitarian spending. In seeking deep cuts across a host of program accounts and pledging to align with American interests, it is ...

Following Treasury Secretary Scott Bessent’s interventions during the World Bank and IMF Spring Meetings and the White House submission of the “skinny” budget to Congress last week, we now have some clarity around the Trump administration’s policy agenda for the international financial institutions ...

As rates of conflict and fragility rise across West Africa and the Sahel, aid flows from the largest donors, including France and the US, decline. These reductions threaten to eliminate life-saving health and food assistance programs, worsening already dire social and humanitarian conditions, partic...